Inhibitor-κB kinase attenuates Hsp90-dependent endothelial nitric oxide synthase function in vascular endothelial...

Area of Science:

• Biochemistry
• Molecular Biology
• Physiology

Background:

• Endothelial nitric oxide (NO) synthase (eNOS) generates vascular NO, with its activity modulated by regulators like heat shock protein 90 (Hsp90).
• Hsp90-dependent phosphorylation is critical for eNOS activity.
• Previous work identified an inhibitor-κB kinase-β (IKKβ)-Hsp90 interaction in high-glucose environments.

Purpose of the Study:

• To define the binding domain of IKKβ on Hsp90.
• To investigate the competitive interaction between IKKβ and eNOS for Hsp90.
• To explore the pathophysiological relevance of the IKKβ-Hsp90 interaction in endothelial dysfunction.

Main Methods:

• Protein-protein interaction mapping to identify IKKβ's binding site on Hsp90.
• Biochemical assays using purified recombinant IKKβ and eNOS-Hsp90 complexes.
• In vitro studies of vascular endothelial growth factor-mediated signaling.
• In vivo studies using an Ins2(Akita) mouse model.

Main Results:

• IKKβ binds to the middle domain of Hsp90, a region also interacting with eNOS.
• Recombinant IKKβ reduces eNOS-Hsp90 complex formation and eNOS activity, indicating competition.
• The IKKβ-Hsp90 interaction is favored in high-glucose conditions, impairing eNOS-Hsp90 interaction.
• Both Hsp90α and Hsp90β isoforms are involved, though preferential involvement is noted.

Conclusions:

• The IKKβ-Hsp90 interaction provides a mechanism for tighter regulation of eNOS activity.
• Competition for Hsp90 between IKKβ and eNOS contributes to high-glucose-induced endothelial dysfunction.
• Maintaining a homeostatic balance of eNOS and IKKβ is crucial for regulating NO production and vascular health in diabetes.